Immediate Reconstruction in Inflammatory Breast Cancer: Challenging Current Care.

about

Immediate Reconstruction in Inflammatory Breast Cancer: Challenging Current Care.

Item

http://www.wikidata.org/entity/Q38957313

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Immediate Reconstruction in Inflammatory Breast Cancer: Challenging Current Care.

@en

type

Item

label

Immediate Reconstruction in Inflammatory Breast Cancer: Challenging Current Care.

@en

prefLabel

Immediate Reconstruction in Inflammatory Breast Cancer: Challenging Current Care.

@en

P1476

Immediate Reconstruction in Inflammatory Breast Cancer: Challenging Current Care

@en

P2093

Ashley B Simpson

http://www.w3.org/2001/XMLSchema#string

Colin O'Rourke

http://www.w3.org/2001/XMLSchema#string

Craig Wengler

http://www.w3.org/2001/XMLSchema#string

Devina McCray

http://www.w3.org/2001/XMLSchema#string

Joseph P Crowe

http://www.w3.org/2001/XMLSchema#string

Rahul Tendulkar

http://www.w3.org/2001/XMLSchema#string

Risal Djohan

http://www.w3.org/2001/XMLSchema#string

Stephen R Grobmyer

http://www.w3.org/2001/XMLSchema#string

P2860

Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy.

Underuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database.

Esthetic reconstruction after mastectomy for inflammatory breast cancer: is it worthwhile?

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Survival of women with inflammatory breast cancer: a large population-based study

Patient-reported Quality of Life and Satisfaction With Cosmetic Outcomes After Breast Conservation and Mastectomy With and Without Reconstruction: Results of a Survey of Breast Cancer Survivors.

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.

Trastuzumab: a review of its use in the management of HER2-positive metastatic and early-stage breast cancer.

Preoperative chemotherapy treatment of breast cancer--a review.

Surgical management of inflammatory breast cancer.

P2888

s10434-016-5554-z

P304

642-648

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-016-5554-Z

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stephanie A Valente

P577

2016-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051290617

http://www.w3.org/2001/XMLSchema#string

P698

27638670

http://www.w3.org/2001/XMLSchema#string